Journey Medical
(NASDAQ) DERM
Journey Medical Financials at a Glance
Market Cap
$198.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$64.68M
Net Income (TTM)
-$9.59M
EPS (TTM)
-$0.38
P/E Ratio
-18.84
Dividend
$0.00
Beta (Volatility)
0.65 (Low)
Dividend
$0.00
Beta (Volatility)
0.65 (Low)
Price
$7.07
Volume
44,456.793
Open
$7.29
Price
$7.07
Volume
44,456.793
Open
$7.29
Previous Close
$7.22
Daily Range
$7.00 - $7.33
52-Week Range
$4.31 - $9.56
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
0.65 (Low)
Price
$7.07
Volume
44,456.793
Open
$7.29
Previous Close
$7.22
Daily Range
$7.00 - $7.33
52-Week Range
$4.31 - $9.56
Estimated Earnings Date
Aug 11, 2026
DERM News
DERM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Journey Medical
Industry
Pharmaceuticals
Sector
Health CareEmployees
58
CEO
Claude Maraoui
Website
www.journeymedicalcorp.comHeadquarters
Scottsdale, AZ 85258, US
DERM Financials
Key Financial Metrics (TTM)
Gross Margin
60.41%
Operating Margin
-9.80%
Net Income Margin
-14.82%
Return on Equity
-35.57%
Return on Capital
-14.27%
Return on Assets
-10.47%
Earnings Yield
-5.31%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$198.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
27.53M
Volume
44.46K
Avg. Volume
273.37K
Financials (TTM)
Gross Profit
$39.07M
Operating Income
-$6.34M
EBITDA
-$1.44M
Operating Cash Flow
-$6.70M
Capital Expenditure
$0.00
Free Cash Flow
-$6.70M
Cash & ST Invst.
$27.22M
Total Debt
$25.47M
Journey Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$15.96M
+21.5%
Gross Profit
$8.62M
+18.3%
Gross Margin
53.99%
N/A
Market Cap
$198.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$4.85M
N/A
Employees
41
N/A
Net Income
-$2.23M
+45.2%
EBITDA
-$189.00K
+91.0%
Quarterly Fundamentals
Total Cash
$27.22M
+29.2%
Total Debt
$25.47M
+1.2%
Accounts Receivable
$24.99M
+38.7%
Inventory
$9.29M
-25.6%
Long Term Debt
$22.87M
-1.4%
Short Term Debt
$2.59M
+31.8%
Return on Assets
-10.47%
N/A
Return on Invested Capital
-11.81%
N/A
Free Cash Flow
$2.91M
+202.7%
Operating Cash Flow
$2.91M
+202.7%